Potentiation of C1 Esterase Inhibitor by StcE, a Metalloprotease Secreted by Escherichia coli O157:H7
Open Access
- 19 April 2004
- journal article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 199 (8) , 1077-1087
- https://doi.org/10.1084/jem.20030255
Abstract
The complement system is an essential component of host defense against pathogens. Previous research in our laboratory identified StcE, a metalloprotease secreted by Escherichia coli O157:H7 that cleaves the serpin C1 esterase inhibitor (C1-INH), a major regulator of the classical complement cascade. Analyses of StcE-treated C1-INH activity revealed that surprisingly, StcE enhanced the ability of C1-INH to inhibit the classical complement-mediated lysis of sheep erythrocytes. StcE directly interacts with both cells and C1-INH, thereby binding C1-INH to the cell surface. This suggests that the augmented activity of StcE-treated C1-INH is due to the increased concentration of C1-INH at the sites of potential lytic complex formation. Indeed, removal of StcE abolishes the ability of C1-INH to bind erythrocyte surfaces, whereas the proteolysis of C1-INH is unnecessary to potentiate its inhibitory activity. Physical analyses showed that StcE interacts with C1-INH within its aminoterminal domain, allowing the unaffected serpin domain to interact with its targets. In addition, StcE-treated C1-INH provides significantly increased serum resistance to E. coli K-12 over native C1-INH. These data suggest that by recruiting C1-INH to cell surfaces, StcE may protect both E. coli O157:H7 and the host cells to which the bacterium adheres from complement-mediated lysis and potentially damaging inflammatory events.Keywords
This publication has 54 references indexed in Scilit:
- Acquisition ofstcE,a C1 Esterase Inhibitor–Specific Metalloprotease, during the Evolution ofEscherichia coliO157:H7The Journal of Infectious Diseases, 2003
- Reactivity of Convalescent-Phase Hemolytic-Uremic Syndrome Patient Sera with the Megaplasmid-Encoded TagA Protein of Shiga Toxigenic Escherichia coli O157Journal of Clinical Microbiology, 2002
- C1 Inhibitor Cross-linking by Tissue TransglutaminaseJournal of Biological Chemistry, 2000
- Regulation of C1-Inhibitor Function by Binding to Type IV Collagen and HeparinBiochemical and Biophysical Research Communications, 1997
- Modulation of Contact System Proteases by GlycosaminoglycansJournal of Biological Chemistry, 1996
- The mechanism by which microorganisms avoid complement attackCurrent Opinion in Immunology, 1992
- Effect of Pseudomonas aeruginosa elastase and alkaline protease on serum complement and isolated components C1q and C3Clinical Immunology and Immunopathology, 1992
- Complement evasion strategies of microorganismsImmunology Today, 1991
- Interaction of 125I‐labelled complement subcomponents Cr and Cs with protease inhibitors in plasmaFEBS Letters, 1979
- Human Serum Inhibitor of C′1 Esterase: Identity with NeuraminoglycoproteinScience, 1969